Schedule 13G ownership disclosure
Olema Pharmaceuticals Inc
Common Stock, par value $0.0001 per share · CUSIP: 68062P106
Event date: 2025-01-08
- Filing-level shares
- 7,095,780
- Percent of class
- 9.99%
- Bain Capital Life Sciences Opportunities IV, L.P.
Shares: 7,095,780 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-004846
- Form type
- SCHEDULE 13G/A
- Filer
- Bain Capital Life Sciences Opportunities IV, L.P.
- CIK
- CIK 2015553
- Filed
- Jan 13, 2025
- Reporting period
- Jan 08, 2025
- Description
- Schedule 13G beneficial ownership